I noticed in today's ASX release the "about Admedus" section at the foot of the release is now omitting the following statement and hasn't since the HSV2 results notice to the ASX
Admedus has commercialised its innovative tissue engineering technology for regenerative medicine in four continents. We also have a major interest in developing the next generation of vaccines with a Brisbane-based research group led by Professor Ian Frazer. The vaccine programmes target disease with significant global potential, such as Herpes and Human Papillomavirus.
Intentional or an error???? or am I missing something?
OTR
I noticed in today's ASX release the "about Admedus" section at...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.35 |
Change
0.040(0.22%) |
Mkt cap ! $352.7M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.13 | $69.15K | 3.766K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 383 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.50 | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 02/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |